Sandra Pisonero Vaquero-rekin lankidetzan egindako argitalpenak (8)

2018

  1. Hepatitis C virus-inuced steatosis

    Fatty liver disease: a reality with many questions (Eolas Ediciones), pp. 299-318

2017

  1. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation

    Free Radical Biology and Medicine, Vol. 102, pp. 188-202

2015

  1. Flavonoids and related compounds in non-alcoholic fatty liver disease therapy

    Current Medicinal Chemistry, Vol. 22, Núm. 25, pp. 2991-3012

  2. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease

    Molecular Nutrition and Food Research, Vol. 59, Núm. 5, pp. 879-893

  3. Repression of the nuclear receptor small heterodimer partner by steatotic drugs and in advanced nonalcoholic fatty liver disease

    Molecular Pharmacology, Vol. 87, Núm. 4, pp. 582-594

2014

  1. Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin

    Laboratory Investigation, Vol. 94, Núm. 3, pp. 262-274

2013

  1. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; And repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1831, Núm. 4, pp. 803-818

2012

  1. Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication

    Laboratory Investigation, Vol. 92, Núm. 8, pp. 1191-1202